一个完全分散的随机对照研究,对在轻度喘中按需要使用的阿尔布特罗尔-布德索尼德固剂量吸入器进行控制:BATURA研究设计
Craig LaForce1, Frank C Albers2, Mark Cooper3
1North Carolina Clinical Research, Chapel Hill, NC, USA.
Journal of asthma and allergy
|August 28, 2024
概括
BATURA研究表明,分散的试验可以改善喘护理的准入. 根据需要使用的阿尔布特罗尔-布德索尼德有效地减少了轻度喘患者的严重喘恶化.
科学领域:
- 肺部病理学 肺部病理学
- 临床试验 临床试验
- 药理学 药理学是指药理学的学科.
背景情况:
- 分散临床试验 (DCT) 通过远程进行活动来提高可访问性,克服时间和距离等参与障碍.
- 阿尔布特罗尔-布德索尼德 (180/160μg pMDI) 是FDA批准的用于管理喘症状和减少喘恶化.
- 轻度喘管理通常涉及短效支气管扩展剂,有机会改进治疗策略.
研究的目的:
- 与阿尔布特罗尔相比,根据需要研究阿尔布特罗尔-布德索尼德在减少严重喘恶化中的有效性.
- 评估完全分散的临床试验模型在招募和管理患有轻度喘的参与者的有效性.
- 在现实环境中评估远程试验程序和药物输送的安全性和可用性.
主要方法:
- 该BATURA研究 (NCT05505734) 是一个3b期,随机,双盲,事件驱动的试验.
- 患有轻度喘的参与者 (≥12岁) 被随机分为1:1接受根据需要的albuterol-budesonide或albuterol pMDI.
- 所有的试验程序,包括同意和访问,都在虚拟进行,药物直接运送给参与者.
主要成果:
- 主要终点是时间至第一次严重喘恶化.
- 二级终点包括年化恶化率和全身性皮质类固醇暴露.
- 通过智能吸入器传感器监测研究药物坚持和使用情况.
结论:
- 分散的试验设计可以显著改善患有喘等慢性疾病的个人的临床研究机会.
- 根据需要,阿尔布特罗尔-布德索尼德显示出作为一种有效的治疗方法来减少轻度喘中严重恶化的潜力.
- BATURA研究证明了进行完全分散的喘试验的可行性和好处.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
241
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
241
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
230
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
230
Inhaled Medications
244
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
244
Asthma: Pathogenesis and Management
376
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
376
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
254
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
254


